Cancer Research Horizons Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8
- Investments
-
52
- Portfolio
-
30
- Exits
-
19
Cancer Research Horizons General Information
Company Description
Founded in 1982, Cancer Research Horizons is a venture capital investment firm based in London, United Kingdom. The firm primarily seeks to invest in cancer research projects, therapeutics, vaccines, diagnostics, artificial intelligence, medical devices, software, and healthcare-focused startups.
Business Details
Website
www.cancerresearchhorizons.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 2 Redman Place
- London E20 1JQ
- England, United Kingdom
Cancer Research Horizons Investments (52)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 52North | 14-Nov-2024 | Later Stage VC | Monitoring Equipment | Generating Revenue | ||
| Súil Vision | 12-Sep-2024 | Other Healthcare Technology Systems | Startup | |||
| Trogenix | 16-Aug-2024 | Biotechnology | Generating Revenue | |||
| Myricx Bio | 08-Jul-2024 | Drug Discovery | Generating Revenue | |||
| Stratosvir | 06-Jun-2024 | Drug Discovery | Generating Revenue | |||
| Infinitopes | 30-Apr-2024 | Biotechnology | Clinical Trials - Phase 2 | |||
| Neobe | 22-Dec-2023 | Biotechnology | Pre-Clinical Trials | |||
| Adendra Therapeutics | 12-Dec-2023 | Biotechnology | Generating Revenue | |||
| NK:IO | 25-Jul-2023 | Seed Round | Drug Discovery | Generating Revenue | ||
| Cyted Health | 18-May-2023 | Later Stage VC | Decision/Risk Analysis | Generating Revenue |
Cancer Research Horizons Exits (19)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Metabomed | 08-Feb-2024 | Out of Business | |
| Arquer Diagnostics | 02-Jan-2024 | ||
| Karus Therapeutics | 18-Dec-2023 | ||
| Macrophage Pharma | 05-Dec-2023 | ||
| AIMM Therapeutics | 01-Feb-2022 | ||
| Cytosystems | 01-Jan-2022 | ||
| GammaDelta Therapeutics | 27-Oct-2021 | ||
| Inivata | 18-Jun-2021 | ||
| Achilles Therapeutics | 31-Mar-2021 | IPO | |
| Chimeric Therapeutics | 18-Jan-2021 | IPO |
Cancer Research Horizons Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Cancer Research Horizons Co-Investors (53)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Cambridge Enterprise | 2 |
|
|
||
| Deep Science Ventures |
|
|
|||
| Old College Capital |
|
|
|||
| Oxford Science Enterprises |
|
|
|||
| The Francis Crick Institute |
|
|
Cancer Research Horizons FAQs
-
What is Cancer Research Horizons?
Founded in 1982, Cancer Research Horizons is a venture capital investment firm based in London, United Kingdom.
-
When was Cancer Research Horizons founded?
Cancer Research Horizons was founded in 1982.
-
Where is Cancer Research Horizons headquartered?
Cancer Research Horizons is headquartered in London, United Kingdom.
-
What is Cancer Research Horizons's total asset value?
Cancer Research Horizons has around in total assets under management.
-
How many investments has Cancer Research Horizons made?
Cancer Research Horizons has made 52 investments.
-
What has Cancer Research Horizons invested in?
Cancer Research Horizons has made numerous investments in companies like 52North, Súil Vision, and Trogenix within the Monitoring Equipment, Healthcare Technology Systems, and Biotechnology industries.
-
What has Cancer Research Horizons invested in recently?
Cancer Research Horizons's latest investment was on 14-Nov-2024 in 52North, a company within the Monitoring Equipment industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
